Neuroscience

How a multiple sclerosis drug reshapes the immune system

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered patients immense hope. The long-awaited drug is a monoclonal antibody that depletes B cells—the immune ...

Psychology & Psychiatry

Fact or fiction? The ADHD info dilemma

TikTok is one of the fastest-growing and most popular social media platforms in the world—especially among college-age individuals. In the United States alone, there are over 136 million TikTok users aged 18 and older, ...

Vaccination

COVID vaccine labels to warn of rare heart risk

The U.S. Food and Drug Administration (FDA) has added new warnings to the Pfizer and Moderna COVID-19 vaccines about a rare heart condition that mostly affects young men.

Oncology & Cancer

UK economy losing billions to cancer

Cancer is costly for patients and the NHS—but it also has a significant impact on the U.K. economy, according to research led by the University of Leeds.

Medical research

Researchers find serious flaws in trials with adult ADHD patients

Millions of adults around the world are diagnosed with ADHD every year, and there is a great need for research in the field. However, much clinical research on adult ADHD suffers from serious methodological shortcomings that ...

page 20 from 40